News & Events
Featured Blog: TreeFrog Therapeutics Q&A
Today, we’re highlighting the groundbreaking work of TreeFrog Therapeutics, a company aimed at making stem cell-derived cell therapies more affordable and accessible to millions of patients. TreeFrog is a resident of our newest facility, LabCentral 238, with on-site capacities to kickstart collaborative cell therapy programs in regenerative medicine and immuno-oncology. We spoke with TreeFrog’s Cofounder and Chief Technology Officer, Kevin Alessandri, Ph.D., who just moved from Bordeaux to Boston, to learn more about the company’s focus and activities.
Gallery 1832
Gallery 1832 provides residents and visitors with new avenues to find inspiration in the space around them. We believe this constantly changing environment and exposure to new perspectives is beneficial to the mind. In this spirit, the gallery space is an important part of keeping life fresh for researchers and entrepreneurs.
News Articles
See All NewsPress Releases
Eight Golden Tickets offer more opportunity for underrepresented biotech entrepreneurs and scientists to benefit from LabCentral's lab space, shared resources and community CAMBRIDGE, Mass., May 15,…Read full post
Eight Golden Tickets offer more opportunity for underrepresented biotech entrepreneurs and scientists to benefit from LabCentral's lab space, shared resources and community CAMBRIDGE, Mass., May 15,…Read full post
New initiative offers range of DEI tools and resources specifically designed for VC firms and their portfolio companies with support from sponsors Johnson & Johnson Innovation-JJDC, Mission…Read full post
Resident and alumni companies also created 1,284 new jobs in 2022 to bring the total to 5,892 new biotech jobs added to the economy by LabCentral companies since 2013 CAMBRIDGE, Mass., April 11, 2023…Read full post
Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health part of group sponsoring LabCentral Ignite’s 2023 Golden Ticket competition and fellowship program supporting diverse founders in…Read full post